RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $512,665 | -79.0% | 60,959 | -68.7% | 0.00% | -100.0% |
| Q2 2023 | $2,445,394 | -13.0% | 194,697 | +14.1% | 0.00% | 0.0% |
| Q1 2023 | $2,810,820 | -28.5% | 170,663 | -35.1% | 0.00% | 0.0% |
| Q4 2022 | $3,930,714 | +762.0% | 263,100 | +1188.1% | 0.00% | – |
| Q3 2022 | $456,000 | -57.9% | 20,426 | -68.4% | 0.00% | – |
| Q2 2022 | $1,082,000 | -69.0% | 64,633 | -44.5% | 0.00% | -100.0% |
| Q1 2022 | $3,488,000 | +20.5% | 116,521 | +23.6% | 0.00% | 0.0% |
| Q4 2021 | $2,894,000 | +743.7% | 94,238 | +765.8% | 0.00% | – |
| Q3 2021 | $343,000 | -69.4% | 10,884 | -64.4% | 0.00% | – |
| Q2 2021 | $1,120,000 | -25.1% | 30,611 | -29.2% | 0.00% | – |
| Q1 2021 | $1,496,000 | +327.4% | 43,261 | +414.3% | 0.00% | – |
| Q4 2020 | $350,000 | +1421.7% | 8,412 | +1460.7% | 0.00% | – |
| Q3 2020 | $23,000 | – | 539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |